Drug survival of tumor necrosis factor α inhibitors in patients with ankylosing spondylitis in Korea
Hyemin Jeong, Yeong Hee Eun, In Young Kim, Hyungjin Kim, Joong Kyong Ahn, Jaejoon Lee, Eun-Mi Koh, Hoon-Suk Cha
Korean J Intern Med. 2018;33(2):407-416. Published online 2016 Oct 12 DOI: https://doi.org/10.3904/kjim.2016.042
Citations to this article as recorded by 
Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network
Guillaume Larid, Guy Baudens, Georges Tiemdjo-Djimaffo, Pascal Coquerelle, Vincent Goeb, Marie Hélène Guyot, Laurent Marguerie, Frédéric Maury, Eric Veillard, Eric Houvenagel, Jean-Hugues Salmon, René-Marc Flipo, Elisabeth Gervais
Scientific Reports.2024;[Epub] CrossRef
Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry
Š Tichý, L Nekvindová, J Baranová, J Vencovský, K Pavelka, P Horák, J Závada
Scandinavian Journal of Rheumatology.2024; : 1. CrossRef
Real-World Adherence and Drug Survival of Biologics among Patients with Ankylosing Spondylitis
Vered Rosenberg, Howard Amital, Gabriel Chodick, Freddy Faccin, Abdulla Watad, Dennis McGonagle, Omer Gendelman
Journal of Clinical Medicine.2024; 13(15): 4480. CrossRef
High Baseline Neutrophil-to-Lymphocyte Ratio Could Serve as a Biomarker for Tumor Necrosis Factor-Alpha Blockers and Their Discontinuation in Patients with Ankylosing Spondylitis
Dong-Hyuk Moon, Aran Kim, Byung-Wook Song, Yun-Kyung Kim, Geun-Tae Kim, Eun-Young Ahn, Min-Wook So, Seung-Geun Lee
Pharmaceuticals.2023; 16(3): 379. CrossRef
Effect of body mass index on treatment response of biologic/targeted-synthetic DMARDs in patients with rheumatoid arthritis, psoriatic arthritis or axial spondyloarthritis. A systematic review
Chrysoula G. Gialouri, Maria Pappa, Gerasimos Evangelatos, Elena Nikiphorou, George E. Fragoulis
Autoimmunity Reviews.2023; 22(7): 103357. CrossRef
Impact of Infliximab Biosimilar CT-P13 Dose and Infusion Interval on Real-World Drug Survival and Effectiveness in Patients with Ankylosing Spondylitis
Shin-Seok Lee, Tae-Hwan Kim, Won Park, Yeong-Wook Song, Chang-Hee Suh, Soo-Kyoung Kim, Dae-Hyun Yoo
Journal of Clinical Medicine.2021; 10(19): 4568. CrossRef
Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis
Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee, Kichul Shin, Hyoun-Ah Kim, Hong Ki Min
Scientific Reports.2021;[Epub] CrossRef
The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis
Axel Svedbom, Johan Dalén, Moa Ivergård, Rebekah H. Borse, Christopher M. Black, Karin Luttropp, Sumesh Kachroo
The European Journal of Health Economics.2020; 21(1): 45. CrossRef
Frequency of peripheral diseases in Korean patients with ankylosing spondylitis and the effectiveness of adalimumab
Sang‐Hoon Lee, Won Park, Sung Won Lee, Hyun Ah Kim, Jung‐Yoon Choe, Sang‐Heon Lee, Shin‐Seok Lee, Sung‐Hwan Park, Min‐Chan Park, Dong‐Hyuk Sheen, Hye Soon Lee, Yeon‐Ah Lee, Yusun Lee, Tae‐Hwan Kim
International Journal of Rheumatic Diseases.2020; 23(9): 1175. CrossRef
Drug Survival of Biologics in Treating Ankylosing Spondylitis: A Systematic Review and Meta-analysis of Real-World Evidence
Chia-Ling Yu, Chung-Han Yang, Ching-Chi Chi
BioDrugs.2020; 34(5): 669. CrossRef
Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice
Ulf Lindström, Tor Olofsson, Sara Wedrén, Ilia Qirjazo, Johan Askling
Arthritis Research & Therapy.2019;[Epub] CrossRef
Adalimumab/etanercept/infliximab
Reactions Weekly.2018; 1698(1): 21. CrossRef
Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona Registry
Philip J. Mease, Désirée van der Heijde, Chitra Karki, Mei Liu, Yujin Park, Jeffrey D. Greenberg
Rheumatology and Therapy.2018; 5(2): 537. CrossRef
Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis
Atul Deodhar, David Yu
Seminars in Arthritis and Rheumatism.2017; 47(3): 343. CrossRef
Association of HLA-B27 with ankylosing spondylitis and clinical features of the HLA-B27-associated ankylosing spondylitis: a meta-analysis
Hai Lin, Yi-Zhen Gong
Rheumatology International.2017; 37(8): 1267. CrossRef